Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

NCT07146503 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Depression and Quality of Life
Treatment Resistant Depression (TRD)
Anhedonia
Apathy
Anxiety
Cognition
Temperament
Psychiatric Comorbidities

Interventions

DRUG: Esketamine (Intranasal Spray)

Sponsor

Riccardo Guglielmo